Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

Asthma III: Clinical Manifestations

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Venous thromboembolism after mechanical restraint in psychiatric hospitals: population based cohort and self-controlled case series study.

BMJ (Clinical research ed.)·2026

Same author

Technology-assisted physical activity among hospitalized medical patients: a cluster randomized trial.

European journal of preventive cardiology·2026

Same author

Cohort Profile: The Central Denmark Cancer Cohort.

Clinical epidemiology·2026

Same author

The Danish Infection Cohort: a resource for population based infectious disease epidemiology.

European journal of epidemiology·2026

Same author

Intoxication in Children From Opioids Prescribed to Family Members.

JAMA network open·2026

Same author

Design and rationale of the COMPARE-TAVI 2 trial: An all-comers head-to-head comparison of Evolut FX+ and Sapien 3 Ultra Resilia transcatheter heart valves.

American heart journal·2026

Same journal

Upper and lower airway crosstalk in acute exacerbations of COPD: a clinical and biological overview.

Expert review of respiratory medicine·2026

Same journal

Short-term exposure to urban air pollution and asthma-related morbidity in children under five: a PRISMA-guided systematic review with narrative synthesis (2021-2025).

Expert review of respiratory medicine·2026

Same journal

Improving the follow-up of children and adults with prematurity-associated lung disease.

Expert review of respiratory medicine·2026

Same journal

A profile on inhaled treprostinil for pulmonary hypertension.

Expert review of respiratory medicine·2026

Same journal

Effect of depemokimab on asthma control and clinical outcomes: a systematic review and meta-analysis of randomized controlled trials.

Expert review of respiratory medicine·2026

Same journal

MicroRNAs in exhaled breath condensate and plasma for diagnosis of asbestos-related interstitial lung diseases.

Expert review of respiratory medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 31, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Asthma in elite athletes.

Jimmi Elers¹, Lars Pedersen, Vibeke Backer

¹Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen NV, Denmark.

Expert Review of Respiratory Medicine

|June 28, 2011

Summary

This summary is machine-generated.

Elite athletes with asthma experience exercise-induced symptoms, differing from non-athletes. Inhaled corticosteroids are key for managing exercise-induced asthma, with careful consideration of medication policies.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Related Experiment Videos

Last Updated: May 31, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Area of Science:

Sports Medicine
Pulmonology
Exercise Physiology

Background:

Asthma is prevalent in elite endurance athletes, often presenting with exercise-induced symptoms rather than at rest.
Elite athletes may exhibit distinct airway inflammation patterns and bronchial reactivity compared to non-athletic individuals with asthma.
Exercise-induced symptoms in athletes can mimic other conditions like inspiratory wheeze or vocal cord dysfunction, potentially limiting performance.

Purpose of the Study:

To summarize the unique aspects of asthma in elite athletes.
To outline diagnostic and treatment strategies for exercise-induced asthma in this population.
To highlight the importance of considering doping regulations in athletic asthma management.

Main Methods:

Review of existing literature on asthma in elite athletes.
Analysis of differences in airway inflammation and response to bronchial provocation tests.
Discussion of therapeutic approaches and anti-doping rules.

Main Results:

Elite athletes with asthma show different inflammatory profiles and responses to tests compared to the general asthmatic population.
Daily use of beta-agonists can lead to tolerance, emphasizing the need for inhaled corticosteroids as primary treatment.
Systemic beta-2 agonist use is prohibited, while inhaled forms are permissible under specific conditions.

Conclusions:

Comprehensive assessment is crucial for diagnosing and grading asthma in elite athletes.
Inhaled corticosteroids are the preferred daily treatment for exercise-induced asthma, superseding regular beta-agonist use.
Physicians must be aware of anti-doping regulations regarding asthma medications in athletes.